BeStock  
Stocks › Medical Devices › AORT

Artivion AORT

US equityMarket cap rank #3235Medical Devices
$18.16 −$0.37 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.16 0.00%
Open$18.52
Prev close$18.53
Day range$18.13 – $18.93
Volume642.1K
Market cap$886.02M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership98.1%+1.83 pts vs. prior quarter
Institutions holding268+11 vs. prior quarter
Insider trades (recent)20 buys / 28 sellsNet selling
Short interest7.00% of floatDays to cover 7.2 · as of 30 Oct 2026
Short-sale volume share28.4%5-day average of daily volume

Short-sale volume as % of daily volume

12%24%36%49%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$921.8K (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

+$954.9KSuper−$1.9MBig−$369.3KMid−$2.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 35.4% of shares outstanding.

Largest holders

  • BlackRock15.06%
  • Macquarie Investment Management Business Trust6.53%
  • Morgan Stanley5.42%
  • Vanguard Capital Management, LLC4.23%
  • Juniper Investment Company, LLC4.14%
  • FMR4.03%
  • State Street Global Advisors4.09%
  • Ophir Asset Management Pty Ltd3.69%

By investor type

  • Mutual Fund73.40%
  • Hedge Fund11.35%
  • Public Company7.04%
  • Individual/Insider4.96%
  • VC/PE Fund3.92%
  • Private Company1.14%
  • Government Pension Fund0.99%
  • Insurance Company0.27%

Reported short interest has risen from 5.63% to 7.00% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +674,491 15.1%
GW&K Investment Management, LLC Mutual Fund 2026/Q3 +538,194 2.7%
abrdn plc Mutual Fund 2026/Q3 +521,089 1.1%
SG Capital Management LLC Hedge Fund 2026/Q3 +484,047 1.0%
Champlain Investment Partners, LLC Mutual Fund 2026/Q3 +291,768 0.6%
Royce & Associates, LP Mutual Fund 2026/Q3 +250,420 1.8%
State Street Global Advisors Mutual Fund 2026/Q3 +135,136 4.1%
Wilshire Advisors LLC Mutual Fund 2026/Q3 +105,698 0.2%
Ophir Asset Management Pty Ltd Mutual Fund 2026/Q3 +849,158 3.7%
Juniper Investment Company, LLC Hedge Fund 2026/Q3 +830,749 4.1%
Citadel Advisors LLC Hedge Fund 2026/Q3 +756,725 1.7%
Macquarie Investment Management Business Trust Mutual Fund 2026/Q3 +728,828 6.5%
Conestoga Capital Advisors, LLC Mutual Fund 2026/Q3 +448,290 3.3%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +431,690 0.9%
Soleus Capital Management, L.P. Hedge Fund 2026/Q3 +388,000 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Sep 2026 Andrew Green Senior Vice President of Regulatory & Quality Open Market Disposition -11,480 $24.97 40,160
2 Sep 2026 Andrew Green Senior Vice President of Regulatory & Quality Intent to Sell (Form 144) -1,493 $26.02 –
2 Sep 2026 Andrew Green Senior Vice President of Regulatory & Quality Open Market Disposition -8,003 $27.27 51,640
1 Sep 2026 Andrew Green Senior Vice President of Regulatory & Quality Intent to Sell (Form 144) -6,510 $27.27 –
26 Aug 2026 Marshall Stanton Former Senior VP of Clinical Research & Chief Medical Officer Intent to Sell (Form 144) -7,400 $26.85 –
18 Aug 2026 James Mackin Chairperson & CEO Open Market Disposition -70,000 $28.96 877,275
13 Aug 2026 Andrew Green Senior Vice President of Regulatory & Quality Open Market Disposition -616 $28.55 59,643
13 Aug 2026 Lance Berry EVP, COO, CFO & Treasurer Open Market Disposition -715 $28.55 210,112
11 Aug 2026 Jean Holloway Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Open Market Disposition -977 $28.49 184,118
10 Jun 2026 Andrew Green Senior Vice President of Regulatory & Quality Derivative Exercise and Sale -44,001 $20.71 60,259
1 Jun 2026 Anthony Semedo Independent Director Other Acquisition +6,325 – 47,560
1 Jun 2026 Anthony Semedo Independent Director Other Disposition -6,325 – 47,560
31 May 2026 Andrew Green Senior Vice President of Regulatory & Quality Initial Statement of Beneficial +0 – 44,001
17 May 2026 James Bullock Independent Director Other Acquisition +7,576 – 76,223
17 May 2026 Thomas Ackerman Independent Director Other Acquisition +7,576 – 157,472
17 May 2026 Anthony Semedo Independent Director Other Acquisition +7,576 – 46,960
17 May 2026 Daniel Bevevino Independent Director Other Acquisition +7,576 – 157,637
17 May 2026 Jeffrey Burbank Independent Director Other Acquisition +7,576 – 61,372
17 May 2026 Jon Salveson Independent Director Other Acquisition +7,576 – 137,416
17 May 2026 Marna Borgstrom Independent Director Other Acquisition +7,576 – 56,664

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 3,412,435 7.0% 7.2
15 Oct 2026 3,735,523 7.7% 7.2
30 Sep 2026 3,621,461 7.4% 5.5
15 Sep 2026 3,284,198 6.7% 5.4
31 Aug 2026 2,927,038 6.0% 4.4
14 Aug 2026 2,745,747 5.6% 3.2

Discussion

No comments yet — be the first to weigh in on AORT.

Sign in to join the discussion.

Scroll to Top